HomeCompareMAHN vs JNJ

MAHN vs JNJ: Dividend Comparison 2026

MAHN yields 1818.18% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAHN wins by $4103414683.81M in total portfolio value
10 years
MAHN
MAHN
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4103414683.84M
Annual income
$3,702,796,788,756,407.00
Full MAHN calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — MAHN vs JNJ

📍 MAHN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMAHNJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MAHN + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MAHN pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MAHN
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$3,147,377,270,442,946.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, MAHN beats the other by $3,147,377,270,438,908.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MAHN + JNJ for your $10,000?

MAHN: 50%JNJ: 50%
100% JNJ50/50100% MAHN
Portfolio after 10yr
$2051707341.93M
Annual income
$1,851,398,394,380,578.50/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MAHN
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MAHN buys
0
JNJ buys
0
No recent congressional trades found for MAHN or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMAHNJNJ
Forward yield1818.18%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$4103414683.84M$30.5K
Annual income after 10y$3,702,796,788,756,407.00$4,749.88
Total dividends collected$4074760433.31M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MAHN vs JNJ ($10,000, DRIP)

YearMAHN PortfolioMAHN Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$192,518$181,818.18$10,594$274.49+$181.9KMAHN
2$3,477,331$3,271,336.99$11,294$360.69+$3.47MMAHN
3$58,943,217$55,222,471.89$12,133$476.91+$58.93MMAHN
4$937,891,469$874,822,227.57$13,156$635.42+$937.88MMAHN
5$14,012,869,532$13,009,325,660.38$14,432$854.61+$14012.86MMAHN
6$196,647,994,247$181,654,223,846.76$16,056$1,162.76+$196647.98MMAHN
7$2,592,865,386,485$2,382,452,032,641.56$18,175$1,604.53+$2592865.37MMAHN
8$32,132,661,421,271$29,358,295,457,731.54$21,009$2,252.68+$32132661.40MMAHN
9$374,409,247,740,494$340,027,300,019,734.44$24,911$3,229.73+$374409247.72MMAHN
10$4,103,414,683,838,736$3,702,796,788,756,407.00$30,458$4,749.88+$4103414683.81MMAHN

MAHN vs JNJ: Complete Analysis 2026

MAHNStock

Mid-Atlantic Home Health Network, Inc. provides integrated home health products and services for the home health care industry in Virginia, Maryland, and the District of Columbia. It also provides healthcare staffing and private duty nursing services to hospitals, nursing homes, and other facilities, such as clinics, correctional facilities, and schools. Mid-Atlantic was incorporated as U-Can Resources, Inc. in 1979. The company changed its name to Petro-Sers Corporation in 1993 and to Mid-Atlantic Home Health Network, Inc. in 1994. The company is based in Manassas, Virginia. Mid-Atlantic Home Health Network, Inc. is 80% owned by Oak Springs NursingHome Limited Liability Company.

Full MAHN Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MAHN vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MAHN vs SCHDMAHN vs JEPIMAHN vs OMAHN vs KOMAHN vs MAINMAHN vs ABBVMAHN vs MRKMAHN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.